Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 139

1.
2.

An epitope-specific DerG-PG70 LEAPS vaccine modulates T cell responses and suppresses arthritis progression in two related murine models of rheumatoid arthritis.

Mikecz K, Glant TT, Markovics A, Rosenthal KS, Kurko J, Carambula RE, Cress S, Steiner HL Rd, Zimmerman DH.

Vaccine. 2017 Jul 13;35(32):4048-4056. doi: 10.1016/j.vaccine.2017.05.009. Epub 2017 Jun 3.

3.

Modified High-Molecular-Weight Hyaluronan Promotes Allergen-Specific Immune Tolerance.

Gebe JA, Yadava K, Ruppert SM, Marshall P, Hill P, Falk BA, Sweere JM, Han H, Kaber G, Medina C, Mikecz K, Ziegler SF, Balaji S, Keswani SG, Perez VA, Butte MJ, Nadeau K, Altemeier WA, Fanger N, Bollyky PL.

Am J Respir Cell Mol Biol. 2017 Jan;56(1):109-120. doi: 10.1165/rcmb.2016-0111OC.

PMID:
27598620
4.

Immune Recognition of Citrullinated Proteoglycan Aggrecan Epitopes in Mice with Proteoglycan-Induced Arthritis and in Patients with Rheumatoid Arthritis.

Markovics A, Ocskó T, Katz RS, Buzás EI, Glant TT, Mikecz K.

PLoS One. 2016 Jul 28;11(7):e0160284. doi: 10.1371/journal.pone.0160284. eCollection 2016.

5.

FTY720 (Gilenya) treatment prevents spontaneous autoimmune myocarditis and dilated cardiomyopathy in transgenic HLA-DQ8-BALB/c mice.

Boldizsar F, Tarjanyi O, Olasz K, Hegyi A, Mikecz K, Glant TT, Rauch TA.

Cardiovasc Pathol. 2016 Sep-Oct;25(5):353-61. doi: 10.1016/j.carpath.2016.05.003. Epub 2016 May 17.

6.

Characterization and Localization of Citrullinated Proteoglycan Aggrecan in Human Articular Cartilage.

Glant TT, Ocsko T, Markovics A, Szekanecz Z, Katz RS, Rauch TA, Mikecz K.

PLoS One. 2016 Mar 4;11(3):e0150784. doi: 10.1371/journal.pone.0150784. eCollection 2016.

7.

Enigma of IL-17 and Th17 Cells in Rheumatoid Arthritis and in Autoimmune Animal Models of Arthritis.

Kugyelka R, Kohl Z, Olasz K, Mikecz K, Rauch TA, Glant TT, Boldizsar F.

Mediators Inflamm. 2016;2016:6145810. doi: 10.1155/2016/6145810. Epub 2016 Jan 20. Review.

8.

Rheumatoid arthritis vaccine therapies: perspectives and lessons from therapeutic ligand epitope antigen presentation system vaccines for models of rheumatoid arthritis.

Rosenthal KS, Mikecz K, Steiner HL 3rd, Glant TT, Finnegan A, Carambula RE, Zimmerman DH.

Expert Rev Vaccines. 2015 Jun;14(6):891-908. doi: 10.1586/14760584.2015.1026330. Epub 2015 Mar 18. Review.

9.

Suppression of proteoglycan-induced autoimmune arthritis by myeloid-derived suppressor cells generated in vitro from murine bone marrow.

Kurkó J, Vida A, Ocskó T, Tryniszewska B, Rauch TA, Glant TT, Szekanecz Z, Mikecz K.

PLoS One. 2014 Nov 4;9(11):e111815. doi: 10.1371/journal.pone.0111815. eCollection 2014.

10.

Identification of myeloid-derived suppressor cells in the synovial fluid of patients with rheumatoid arthritis: a pilot study.

Kurkó J, Vida A, Glant TT, Scanzello CR, Katz RS, Nair A, Szekanecz Z, Mikecz K.

BMC Musculoskelet Disord. 2014 Aug 19;15:281. doi: 10.1186/1471-2474-15-281.

11.

Proteoglycan aggrecan conducting T cell activation and apoptosis in a murine model of rheumatoid arthritis.

Hanyecz A, Olasz K, Tarjanyi O, Nemeth P, Mikecz K, Glant TT, Boldizsar F.

Biomed Res Int. 2014;2014:942148. doi: 10.1155/2014/942148. Epub 2014 Jan 29. Review.

12.

Epigenetics in the pathogenesis of rheumatoid arthritis.

Glant TT, Mikecz K, Rauch TA.

BMC Med. 2014 Feb 26;12:35. doi: 10.1186/1741-7015-12-35. Review.

13.

Of mice and men: how animal models advance our understanding of T-cell function in RA.

Kobezda T, Ghassemi-Nejad S, Mikecz K, Glant TT, Szekanecz Z.

Nat Rev Rheumatol. 2014 Mar;10(3):160-70. doi: 10.1038/nrrheum.2013.205. Epub 2014 Jan 7. Review.

14.

ADAMTS5 is required for biomechanically-stimulated healing of murine tendinopathy.

Bell R, Li J, Shewman EF, Galante JO, Cole BJ, Bach BR Jr, Troy KL, Mikecz K, Sandy JD, Plaas AH, Wang VM.

J Orthop Res. 2013 Oct;31(10):1540-8. doi: 10.1002/jor.22398. Epub 2013 Jun 10.

15.

Differentially expressed epigenome modifiers, including aurora kinases A and B, in immune cells in rheumatoid arthritis in humans and mouse models.

Glant TT, Besenyei T, Kádár A, Kurkó J, Tryniszewska B, Gál J, Soós G, Szekanecz Z, Hoffmann G, Block JA, Katz RS, Mikecz K, Rauch TA.

Arthritis Rheum. 2013 Jul;65(7):1725-35. doi: 10.1002/art.37986.

16.

The role of citrullination of an immunodominant proteoglycan (PG) aggrecan T cell epitope in BALB/c mice with PG-induced arthritis.

Misják P, Bősze S, Horváti K, Pásztói M, Pálóczi K, Holub MC, Szakács F, Aradi B, György B, Szabó TG, Nagy G, Glant TT, Mikecz K, Falus A, Buzás EI.

Immunol Lett. 2013 Apr;152(1):25-31. doi: 10.1016/j.imlet.2013.03.005. Epub 2013 Apr 8.

PMID:
23578666
17.

Pharmacogenetics and pharmacogenomics in rheumatology.

Szekanecz Z, Meskó B, Poliska S, Váncsa A, Szamosi S, Végh E, Simkovics E, Laki J, Kurkó J, Besenyei T, Mikecz K, Glant TT, Nagy L.

Immunol Res. 2013 Jul;56(2-3):325-33. doi: 10.1007/s12026-013-8405-z. Review.

18.

Genetics of rheumatoid arthritis - a comprehensive review.

Kurkó J, Besenyei T, Laki J, Glant TT, Mikecz K, Szekanecz Z.

Clin Rev Allergy Immunol. 2013 Oct;45(2):170-9. doi: 10.1007/s12016-012-8346-7. Review.

19.

Non-MHC risk alleles in rheumatoid arthritis and in the syntenic chromosome regions of corresponding animal models.

Besenyei T, Kadar A, Tryniszewska B, Kurko J, Rauch TA, Glant TT, Mikecz K, Szekanecz Z.

Clin Dev Immunol. 2012;2012:284751. doi: 10.1155/2012/284751. Epub 2012 Dec 6. Review.

20.

Irreversible heavy chain transfer to hyaluronan oligosaccharides by tumor necrosis factor-stimulated gene-6.

Lauer ME, Glant TT, Mikecz K, DeAngelis PL, Haller FM, Husni ME, Hascall VC, Calabro A.

J Biol Chem. 2013 Jan 4;288(1):205-14. doi: 10.1074/jbc.M112.403998. Epub 2012 Nov 19.

Supplemental Content

Loading ...
Support Center